International Journal of Surgical Oncology

Multimodal Treatment of Gastric Cancer: Surgery, Chemotherapy, Radiotherapy, and Timing


Publishing date
13 Jul 2012
Status
Published
Submission deadline
13 Jan 2012

Lead Editor
Guest Editors

1General Oncologic Surgery, Careggi University Hospital, Florence, Italy


Multimodal Treatment of Gastric Cancer: Surgery, Chemotherapy, Radiotherapy, and Timing

Description

In the scenario of gastric cancer treatment surgery is no more alone since many years. Although the encouraging results of adjuvant chemotherapy with S-1 obtained in Japan were not achieved in Western countries, a novel approach, after the results of MAGIC trial published in 2006, has been introduced with pre- or perioperative chemotherapy in the West, with many trials ongoing.

Radiotherapy has been used for many years now in USA with good results and is part of many schedules in Europe as well. Chemotherapy has been proposed even in an intraperitoneal setting with hyperthermia, after extensive resection and peritonectomy.

Multimodal treatment is therefore mandatory, to date, for gastric cancer, but timing, type of therapies, and schedules seem to be a puzzle yet.

We invite investigators to submit original articles and reviews of the literature to shed light on this topic.

Our prominent interests are on results in terms of overall survival with different multimodal schedules as well as complete response to preoperative treatments. Moreover impact of multimodal treatments on surgical perioperative complications and side effects should be taken into account. Particularly significant are those studies which investigate factors and methods capable of predicting multimodal treatments response for different patients in order to tailor a specific treatment to each case. Translational research, molecular genetics, and molecular diagnostics are of utmost interest for such a prospective. Potential topics include, but are not limited to:

  • Recent results in multimodal treatment of gastric cancer
  • Different schedule of multimodal treatment, their feasibility, and their results
  • Patients selection, inclusion, and exclusion criteria for multimodal treatments
  • Prediction of response and diagnostic tools
  • Advance in translational research and molecular genetics and diagnostics
  • Advance in predictors and prognostic factors identification

Before submission authors should carefully read over the journal's Author Guidelines, which are located at http://www.hindawi.com/journals/ijso/guidelines/. Prospective authors should submit an electronic copy of their complete manuscript through the journal Manuscript Tracking System at http://mts.hindawi.com/ according to the following timetable:


Articles

  • Special Issue
  • - Volume 2012
  • - Article ID 246290
  • - Editorial

Multimodal Treatment of Gastric Cancer: Surgery, Chemotherapy, Radiotherapy, and Timing

Marco Bernini | Lapo Bencini
  • Special Issue
  • - Volume 2012
  • - Article ID 148420
  • - Research Article

Effects of Neoadjuvant Intraperitoneal/Systemic Chemotherapy (Bidirectional Chemotherapy) for the Treatment of Patients with Peritoneal Metastasis from Gastric Cancer

Yutaka Yonemura | Ayman Elnemr | ... | Yan Li
  • Special Issue
  • - Volume 2012
  • - Article ID 868645
  • - Review Article

Immunohistochemical Biomarkers in Gastric Cancer Research and Management

Elena Lastraioli | Maria Raffaella Romoli | Annarosa Arcangeli
  • Special Issue
  • - Volume 2012
  • - Article ID 307670
  • - Research Article

Survival Benefit of Adjuvant Radiation Therapy for Gastric Cancer following Gastrectomy and Extended Lymphadenectomy

R. A. Snyder | E. T. Castaldo | ... | N. B. Merchant
  • Special Issue
  • - Volume 2012
  • - Article ID 405652
  • - Review Article

Surgical Treatment of Peritoneal Carcinomatosis from Gastric Cancer

Kiran K. Turaga | T. Clark Gamblin | Sam Pappas
  • Special Issue
  • - Volume 2012
  • - Article ID 862879
  • - Review Article

Mechanisms of Cisplatin-Induced Apoptosis and of Cisplatin Sensitivity: Potential of BIN1 to Act as a Potent Predictor of Cisplatin Sensitivity in Gastric Cancer Treatment

Satoshi Tanida | Tsutomu Mizoshita | ... | Takashi Joh
  • Special Issue
  • - Volume 2012
  • - Article ID 301530
  • - Clinical Study

The Significance of Splenectomy for Advanced Proximal Gastric Cancer

Atsushi Nashimoto | Hiroshi Yabusaki | Atsushi Matsuki
  • Special Issue
  • - Volume 2012
  • - Article ID 379210
  • - Clinical Study

Additional Gastrectomy after Endoscopic Submucosal Dissection for Early Gastric Cancer Patients with Comorbidities

Naohiko Koide | Daisuke Takeuchi | ... | Shinichi Miyagawa
International Journal of Surgical Oncology
 Journal metrics
Acceptance rate27%
Submission to final decision88 days
Acceptance to publication32 days
CiteScore1.880
Impact Factor-
 Submit

We are committed to sharing findings related to COVID-19 as quickly and safely as possible. Any author submitting a COVID-19 paper should notify us at help@hindawi.com to ensure their research is fast-tracked and made available on a preprint server as soon as possible. We will be providing unlimited waivers of publication charges for accepted articles related to COVID-19.